Compare KNSA & BRBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | KNSA | BRBR |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Packaged Foods |
| Sector | Health Care | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.4B | 4.0B |
| IPO Year | 2018 | 2019 |
| Metric | KNSA | BRBR |
|---|---|---|
| Price | $46.37 | $16.83 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 16 |
| Target Price | ★ $55.29 | $43.56 |
| AVG Volume (30 Days) | 574.8K | ★ 2.9M |
| Earning Date | 01-01-0001 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 225.00 | N/A |
| EPS | ★ 0.75 | 0.36 |
| Revenue | $677,564,000.00 | ★ $2,316,600,000.00 |
| Revenue This Year | $38.01 | $6.36 |
| Revenue Next Year | $17.42 | $6.05 |
| P/E Ratio | $61.77 | ★ $48.94 |
| Revenue Growth | ★ 60.09 | 16.05 |
| 52 Week Low | $18.26 | $16.05 |
| 52 Week High | $49.12 | $79.57 |
| Indicator | KNSA | BRBR |
|---|---|---|
| Relative Strength Index (RSI) | 55.14 | 35.43 |
| Support Level | $40.47 | N/A |
| Resistance Level | $46.48 | $19.35 |
| Average True Range (ATR) | 2.16 | 0.97 |
| MACD | 0.00 | 0.18 |
| Stochastic Oscillator | 64.75 | 25.46 |
Kiniksa Pharmaceuticals International PLC is a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing, and commercializing therapeutic medicines for patients suffering from debilitating diseases. The company's clinical-stage product candidates include Rilonacept, abiprubart, and mavrilimumab.
BellRing Brands Inc is a United States-based company engaged in providing nutrition-related products. Its brands, Premier Protein, Dymatize, and PowerBar provides various products including ready-to-drink protein shakes, powders and nutrition bars. The company's products are distributed through a diverse network of channel including club, food, drug and mass, eCommerce, convenience and specialty.